The Powell Perspective

Quince Therapeutics' Phase 3 trial completion for Ataxia-Telangiectasia offers hope, but the real story is its innovative red blood cell drug delivery platform.

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

Beyond the dividend payout, Cherry Hill Mortgage's strategy reveals a deeper pivot towards digital innovation, balancing high yields with new frontiers of risk.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

Lion Group's $8M Bitcoin purchase highlights a growing corporate trend, but a plunging stock price reveals the immense risks of digital asset treasuries.

A new class of AI-driven blood tests can detect lung cancer recurrence years before imaging, shaking up patient care and the multi-billion dollar diagnostics market.

After a difficult post-IPO year, Amaze Holdings is shedding debt and leveraging AI to redefine creator monetization. Is its new strategy the future?

Streamex's $12.2M stake in Empress Royalty isn't just a purchase; it's a blueprint for tokenizing real-world assets and reshaping commodity markets.

Praxis Precision Medicines secures a clear path to market for its rare epilepsy drug, blending genetic science with a savvy regulatory strategy.

Abeona Therapeutics' new treatment center for ZEVASKYN marks a strategic leap in gene therapy access, but what does it mean for patients and the market?

Match Group bets big on the future of dating, spinning out an AI venture while a new CEO steers Hinge toward its projected $1 billion revenue goal.

Annaly Capital's consistent dividend payout raises key questions about strategy, risk, and the future of the mortgage REIT sector. What does it signal?

A hedge fund's 2.34% derivatives stake in Alphawave IP suggests a major acquisition by Qualcomm, highlighting a high-stakes battle for key chip IP.

With a $10M loan and a SPAC deal, Everli is betting on tech and partnerships to win Italy's competitive online grocery market. But can it deliver profits?

While the container market faces a glut, Euroseas locks in 3-year deals, showcasing a masterclass in strategic foresight and financial resilience.

A class-action suit claims Primo Brands hid merger problems behind a perfect narrative. This is a deep dive into corporate spin and shareholder risk.

Ledger Investing launches Korra, a battle-tested SaaS platform using AI to bring transparency and efficiency to the complex casualty ILS market.

Destra's fund is boosting distributions by over 21%. We dissect the proprietary strategy driving this yield and the risks investors must consider.

A fierce bidding war for Avadel Pharmaceuticals reveals the high value of its key drug, as filings from giants like State Street highlight M&A transparency.

Netcapital's huge 1M share grant to its new CEO is a high-stakes play. We decode the strategy, the risk, and the ambitious revenue targets.